Reprieve Cardiovascular Nabs $42M to Expand Intelligent Fluid Management for Heart Failure

Reprieve Cardiovascular, a pioneer in personalized fluid management for acute decompensated heart failure (ADHF) emerges from stealth launching with $42M in Series A financing round.

Related Keywords

United States ,Americans , ,Should Know ,Reprieve Cardiovascular ,Lightstone Ventures ,Sante Ventures ,Deerfield Management ,Genesis Capital ,Arboretum Ventures ,Personalized Approach ,Clinical Progress ,Future Plans ,